Genital shedding of HIV after scheduled treatment interruption-Reference-Cited by-同舟云学术

Genital shedding of HIV after scheduled treatment interruption

Published:2011-02 Issue:2 Volume:22 Page:61-66
ISSN:0956-4624
Container-title:International Journal of STD & AIDS
language:en
Short-container-title:Int J STD AIDS

Author:

Ananworanich J¹²³,Kerr S J¹⁴,Vernazza P⁵,Mangclaviraj S¹,Chaithongwongwatthana S³,Chotnopparatpattara P³,Mahanontharit A¹,Ubolyam S¹,Jupimai T¹,Cooper D A⁴,Ruxrungtham K¹³,Hirschel B⁶

Affiliation:

1. The HIV Netherlands Australia Thailand Research Collaboration

2. South East Asia Research Collaboration with Hawaii, Bangkok, Thailand

3. Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

4. National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia

5. University of St Galen, St Galen, Switzerland

6. Geneva University Hospital, Geneva, Switzerland

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Public Health, Environmental and Occupational Health,Dermatology

Link

http://journals.sagepub.com/doi/pdf/10.1258/ijsa.2010.009594

Reference35 articles.

1. HIV transmission under highly active antiretroviral therapy

2. Universal Voluntary Testing and Treatment for Prevention of HIV Transmission

3. Rates of HIV‐1 Transmission per Coital Act, by Stage of HIV‐1 Infection, in Rakai, Uganda

4. Approaching "HIV elimination": Interventions for acute HIV infection

5. Cervical Shedding of HIV-1 RNA Among Women With Low Levels of Viremia While Receiving Highly Active Antiretroviral Therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of sampling methods to measure HIV RNA viral load in female genital tract secretions;American Journal of Reproductive Immunology;2017-01-23

2. HIV-1 RNA Levels and Antiretroviral Drug Resistance in Blood and Non-Blood Compartments from HIV-1–Infected Men and Women enrolled in AIDS Clinical Trials Group Study A5077;PLoS ONE;2014-04-03

3. HIV-1 genital shedding in HIV-infected patients randomized to second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir;Antiviral Therapy;2014